Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: An Efficacy Study
Status:
Not yet recruiting
Trial end date:
2027-03-31
Target enrollment:
Participant gender:
Summary
Trauma is the leading cause of death and disability in children in the United States. The
objective of this study is to evaluate the benefits and harms of tranexamic acid (TXA; a drug
that stops bleeding) in severely injured children with hemorrhagic brain and/or torso
injuries. Using thromboelastography, we will measure baseline fibrinolysis to assess for
treatment effects of TXA at different levels of fibrinolysis.
Phase:
Phase 3
Details
Lead Sponsor:
Daniel Nishijima, MD, MAS University of California, Davis